[Public Notice+] i-SENS Transitions to Dual CEO System with Cha Geun-sik and Nam Hak-hyun
[Asia Economy Reporter Eunmo Koo] i-SENS announced on the 10th through a public disclosure that it will transition to a dual CEO system. i-SENS was founded by CEO Cha Geun-sik, a former chemistry professor at Kwangwoon University, and President Nam Hak-hyun (CTO·Chief Technology Officer), who developed a blood glucose meter using domestic technology in 2000.
The two started their joint venture while working as university professors and have expanded their business scale based on technological competitiveness by introducing self-monitoring blood glucose products and various other products domestically. After 20 years since its establishment, i-SENS decided to switch to a dual CEO system to enhance management efficiency and stability, as well as to establish a faster decision-making structure.
With the transition to the dual CEO system, CEO Nam Hak-hyun plans to lead i-SENS in the technology research sector to ensure it continues to be a specialized biosensor company. Meanwhile, CEO Cha Geun-sik is expected to focus all efforts on strengthening overall business efficiency at i-SENS based on his 20 years of experience as the company’s CEO.
Hot Picks Today
At President Lee's Call to "Give Enough to Shock," Whistleblower Rewards Become a Real Lottery
- If They Fail Next Year, Bonus Drops to 97 Million Won... A Closer Look at Samsung Electronics DS Division’s 600M vs 460M vs 160M Performance Bonuses
- Lived as Family for Over 30 Years... Daughter-in-Law Cast Aside After Husband's Death
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
i-SENS has been operating in the biosensor-based blood glucose and POCT business, gaining recognition for its technology not only domestically but also in the global market, continuously expanding its market share in blood glucose-related products worldwide.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.